A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
Clinical trial NCT05519839 · COMPLETED
Trial details
- NCT number
- NCT05519839
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2023-07-25
- Enrollment
- 1579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.